English

LIFECORE BIOMEDICAL, INC.

EDGAR

LFCR Current report (8-K) · filed 2026-10-20

204 filing records in this dataset, filed from 1996-06-14 to 2026-10-20. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

153 million USD

2019-05-26 · USD

Exact inputs and evidence

Revenue: 152780000 USD Source

Operating margin

1.62%

2019 Q4 · %

Exact inputs and evidence

Operating Income: 5475000 USD Source
Operating Income: 2995000 USD Source
Revenue: 152780000 USD Source

Operating cash flow

-1.43 million USD

2019-05-26 · USD

Exact inputs and evidence

Operating Cash Flow: 16020000 USD Source
Operating Cash Flow: 17449000 USD Source

Free cash flow

-13 million USD

2019-05-26 · USD

Exact inputs and evidence

Operating Cash Flow: 16020000 USD Source
Operating Cash Flow: 17449000 USD Source
Capital Expenditure: 44734000 USD Source
Capital Expenditure: 33144000 USD Source

Cash and cash equivalents: 17.2 million USD 2026-06-30 Source
Exact value

17241000 USD
Long-term debt including current maturities: 155 million USD 2026-06-30 Source
Exact value

155068000 USD
Shares outstanding: 37.7 million shares 2026-06-30 Source
Exact value

37697012 shares

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-20.

Financial data available through: 2025-05-25.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2019-05-26
Operating income: 9 of 11 periods available· newest 2025-05-25
Net income: 9 of 11 periods available· newest 2025-05-25
Operating cash flow: 9 of 11 periods available· newest 2025-05-25
Capital expenditure: 8 of 11 periods available· newest 2025-05-25
Total assets: 9 of 11 periods available· newest 2025-05-25
Total liabilities: 8 of 11 periods available· newest 2025-05-25
Current assets: 8 of 11 periods available· newest 2025-05-25
Current liabilities: 8 of 11 periods available· newest 2025-05-25
Cash and cash equivalents: 9 of 11 periods available· newest 2025-05-25
Long-term debt including current maturities: 8 of 11 periods available· newest 2025-05-25
Shares outstanding: 8 of 11 periods available· newest 2025-05-25

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
-422.3%

Prior period

USD 12.01 million

2023-05-29 – 2024-05-26
Current period

−USD 38.72 million

2024-05-27 – 2025-05-25

Exact inputs and evidence

-38717000 − 12013000 = -50730000 USD

12013000 USD · 2023-05-29 – 2024-05-26
Inspect prior input Prior source
-38717000 USD · 2024-05-27 – 2025-05-25
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · LIFECORE BIOMEDICAL, INC. · 2025-05-25 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Year-over-year change in Net income: -50730000 USD Concept: fundies:NetIncome Period: 2024-05-27 to 2025-05-25 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -38717000 USD (2024-05-27 to 2025-05-25) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000108/lfcr-20250525.htm#861185 Filing: 000100528625000108 Input fundies:NetIncome: 12013000 USD (2023-05-29 to 2024-05-26) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000108/lfcr-20250525.htm#861957 Filing: 000100528625000108
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-180.2%

Prior period

USD 257,000

2023-05-29 – 2024-05-26
Current period

−USD 206,000

2024-05-27 – 2025-05-25

Exact inputs and evidence

-206000 − 257000 = -463000 USD

257000 USD · 2023-05-29 – 2024-05-26
Inspect prior input Prior source
-206000 USD · 2024-05-27 – 2025-05-25
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · LIFECORE BIOMEDICAL, INC. · 2025-05-25 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Year-over-year change in Operating cash flow: -463000 USD Concept: fundies:OperatingCashFlow Period: 2024-05-27 to 2025-05-25 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -206000 USD (2024-05-27 to 2025-05-25) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000108/lfcr-20250525.htm#882000 Filing: 000100528625000108 Input fundies:OperatingCashFlow: 257000 USD (2023-05-29 to 2024-05-26) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000108/lfcr-20250525.htm#882619 Filing: 000100528625000108
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-27.1%

Prior period

USD 18.4 million

2023-05-29 – 2024-05-26
Current period

USD 13.42 million

2024-05-27 – 2025-05-25

Exact inputs and evidence

13415000 − 18395000 = -4980000 USD

18395000 USD · 2023-05-29 – 2024-05-26
Inspect prior input Prior source
13415000 USD · 2024-05-27 – 2025-05-25
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · LIFECORE BIOMEDICAL, INC. · 2025-05-25 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Year-over-year change in Capital expenditure: -4980000 USD Concept: fundies:CapitalExpenditure Period: 2024-05-27 to 2025-05-25 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 13415000 USD (2024-05-27 to 2025-05-25) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000108/lfcr-20250525.htm#883996 Filing: 000100528625000108 Input fundies:CapitalExpenditure: 18395000 USD (2023-05-29 to 2024-05-26) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000108/lfcr-20250525.htm#884587 Filing: 000100528625000108
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2019 2018-05-28 – 2019-05-26

Revenue USD 557.56 million 100% of revenue
Cost of revenue USD 476.56 million 85% of revenue
Operating expenses USD 75.53 million 14% of revenue
Operating income USD 5.48 million 1% of revenue
Tax, interest and other Derived USD 5.06 million 0.9% of revenue
Net income USD 411,000 0.1% of revenue

Cash

Operating cash flow USD 16.02 million 2.9% of revenue
Capital expenditure USD 44.73 million 8% of revenue
Free cash flow Derived −USD 28.71 million −5.1% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2018 Net income was higher than operating income, so the split is not drawn.
2019 99%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2018 2017-05-29 – 2018-05-27	524227000	510640000 Derived	13587000	-11242000 Derived	24829000	-13811000 Derived	Source 2017-05-29 – 2018-05-27: 524227000 USD Inspect Revenue Open source 2017-05-29 – 2018-05-27: 13587000 USD Inspect Operating Income Open source 2017-05-29 – 2018-05-27: 24829000 USD Inspect Net Income Open source 2017-05-29 – 2018-05-27: 19779000 USD Inspect Operating Cash Flow Open source 2017-05-29 – 2018-05-27: 33590000 USD Inspect Capital Expenditure Open source
2019 2018-05-28 – 2019-05-26	557559000	552084000 Derived	5475000	5064000 Derived	411000	-28714000 Derived	Source 2018-05-28 – 2019-05-26: 557559000 USD Inspect Revenue Open source 2018-05-28 – 2019-05-26: 5475000 USD Inspect Operating Income Open source 2018-05-28 – 2019-05-26: 411000 USD Inspect Net Income Open source 2018-05-28 – 2019-05-26: 16020000 USD Inspect Operating Cash Flow Open source 2018-05-28 – 2019-05-26: 44734000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 557.6M 2019

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-05-27	Revenue	524227000	Revenue: 524227000 Open source
20192019-05-26	Revenue	557559000	Revenue: 557559000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

6.4% 2019

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20182018-05-27	Year over year	No prior comparable period	Revenue: 524227000 Open source
20192019-05-26	Year over year	6.4%	Revenue: 557559000 Open source Revenue: 524227000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 1% 2019

Net margin 0.1% 2019

Free cash flow margin -5.1% 2019

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20182018-05-27	Operating margin	2.6%	Operating Income: 13587000 Open source Revenue: 524227000 Open source
20192019-05-26	Operating margin	1%	Operating Income: 5475000 Open source Revenue: 557559000 Open source
20182018-05-27	Net margin	4.7%	Net Income: 24829000 Open source Revenue: 524227000 Open source
20192019-05-26	Net margin	0.1%	Net Income: 411000 Open source Revenue: 557559000 Open source
20182018-05-27	Free cash flow margin	-2.6%	Revenue: 524227000 Open source Operating Cash Flow: 19779000 Open source Capital Expenditure: 33590000 Open source
20192019-05-26	Free cash flow margin	-5.1%	Revenue: 557559000 Open source Operating Cash Flow: 16020000 Open source Capital Expenditure: 44734000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 16M 2019

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-05-27	Operating cash flow	19779000	Operating Cash Flow: 19779000 Open source
20192019-05-26	Operating cash flow	16020000	Operating Cash Flow: 16020000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -28.7M 2019

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-05-27	Free cash flow	-13811000	Operating Cash Flow: 19779000 Open source Capital Expenditure: 33590000 Open source
20192019-05-26	Free cash flow	-28714000	Operating Cash Flow: 16020000 Open source Capital Expenditure: 44734000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

48% 2019

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20182018-05-27	Liabilities / assets	37.6%	Total Liabilities: 152141000 Open source Total Assets: 404703000 Open source
20192019-05-26	Liabilities / assets	48%	Total Liabilities: 248947000 Open source Total Assets: 519091000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.97× 2019

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20182018-05-27	Current assets / current liabilities	1.1×	Current Assets: 97063000 Open source Current Liabilities: 88375000 Open source
20192019-05-26	Current assets / current liabilities	0.97×	Current Assets: 133041000 Open source Current Liabilities: 137091000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2016-05-30 – 2017-05-28	USD 10.59 million Exact value Exact value: 10590000 USD 2016-05-30 – 2017-05-28: 10590000 USD Inspect Net Income Open source Share or cite Citation for Net Income · LIFECORE BIOMEDICAL, INC. · 2017-05-28 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Net Income: 10590000 USD Concept: fundies:NetIncome Period: 2016-05-30 to 2017-05-28 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3ANetIncome&period=2017-05-28&surface=latest&period_type=duration&start=2016-05-30&unit=USD&dimensions= Input fundies:NetIncome: 10590000 USD (2016-05-30 to 2017-05-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000162828019009791/lndc-20190526.xml#459125 Filing: 000162828019009791 The citation records this snapshot. The page link may show a newer release later.	USD 29.84 million Exact value Exact value: 29838000 USD 2016-05-30 – 2017-05-28: 29838000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LIFECORE BIOMEDICAL, INC. · 2017-05-28 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Operating Cash Flow: 29838000 USD Concept: fundies:OperatingCashFlow Period: 2016-05-30 to 2017-05-28 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3AOperatingCashFlow&period=2017-05-28&surface=latest&period_type=duration&start=2016-05-30&unit=USD&dimensions= Input fundies:OperatingCashFlow: 29838000 USD (2016-05-30 to 2017-05-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000162828019009791/lndc-20190526.xml#458492 Filing: 000162828019009791 The citation records this snapshot. The page link may show a newer release later.	USD 23 million Exact value Exact value: 23003000 USD 2016-05-30 – 2017-05-28: 23003000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LIFECORE BIOMEDICAL, INC. · 2017-05-28 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Capital Expenditure: 23003000 USD Concept: fundies:CapitalExpenditure Period: 2016-05-30 to 2017-05-28 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3ACapitalExpenditure&period=2017-05-28&surface=latest&period_type=duration&start=2016-05-30&unit=USD&dimensions= Input fundies:CapitalExpenditure: 23003000 USD (2016-05-30 to 2017-05-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000162828019009791/lndc-20190526.xml#479476 Filing: 000162828019009791 The citation records this snapshot. The page link may show a newer release later.	USD 6.84 million Calculation and evidence 29838000 − 23003000 USD Exact free cash flow: 6835000 USD 2016-05-30 – 2017-05-28: 29838000 USD · Inspect Operating Cash Flow · Source 2016-05-30 – 2017-05-28: 23003000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LIFECORE BIOMEDICAL, INC. · 2017-05-28 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Free cash flow: 6835000 USD Concept: free-cash-flow Period: 2016-05-30 to 2017-05-28 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 29838000 USD (2016-05-30 to 2017-05-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000162828019009791/lndc-20190526.xml#458492 Filing: 000162828019009791 Input fundies:CapitalExpenditure: 23003000 USD (2016-05-30 to 2017-05-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000162828019009791/lndc-20190526.xml#479476 Filing: 000162828019009791 The citation records this snapshot. The page link may show a newer release later.
2018 2017-05-29 – 2018-05-27	USD 24.83 million Exact value Exact value: 24829000 USD 2017-05-29 – 2018-05-27: 24829000 USD Inspect Net Income Open source Share or cite Citation for Net Income · LIFECORE BIOMEDICAL, INC. · 2018-05-27 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Net Income: 24829000 USD Concept: fundies:NetIncome Period: 2017-05-29 to 2018-05-27 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3ANetIncome&period=2018-05-27&surface=latest&period_type=duration&start=2017-05-29&unit=USD&dimensions= Input fundies:NetIncome: 24829000 USD (2017-05-29 to 2018-05-27) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528620000004/lndc-20200531.htm#1955005 Filing: 000100528620000004 The citation records this snapshot. The page link may show a newer release later.	USD 19.78 million Exact value Exact value: 19779000 USD 2017-05-29 – 2018-05-27: 19779000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LIFECORE BIOMEDICAL, INC. · 2018-05-27 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Operating Cash Flow: 19779000 USD Concept: fundies:OperatingCashFlow Period: 2017-05-29 to 2018-05-27 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3AOperatingCashFlow&period=2018-05-27&surface=latest&period_type=duration&start=2017-05-29&unit=USD&dimensions= Input fundies:OperatingCashFlow: 19779000 USD (2017-05-29 to 2018-05-27) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528620000004/lndc-20200531.htm#1602317 Filing: 000100528620000004 The citation records this snapshot. The page link may show a newer release later.	USD 33.59 million Exact value Exact value: 33590000 USD 2017-05-29 – 2018-05-27: 33590000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LIFECORE BIOMEDICAL, INC. · 2018-05-27 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Capital Expenditure: 33590000 USD Concept: fundies:CapitalExpenditure Period: 2017-05-29 to 2018-05-27 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3ACapitalExpenditure&period=2018-05-27&surface=latest&period_type=duration&start=2017-05-29&unit=USD&dimensions= Input fundies:CapitalExpenditure: 33590000 USD (2017-05-29 to 2018-05-27) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528620000004/lndc-20200531.htm#3260659 Filing: 000100528620000004 The citation records this snapshot. The page link may show a newer release later.	−USD 13.81 million Calculation and evidence 19779000 − 33590000 USD Exact free cash flow: -13811000 USD 2017-05-29 – 2018-05-27: 19779000 USD · Inspect Operating Cash Flow · Source 2017-05-29 – 2018-05-27: 33590000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LIFECORE BIOMEDICAL, INC. · 2018-05-27 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Free cash flow: -13811000 USD Concept: free-cash-flow Period: 2017-05-29 to 2018-05-27 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 19779000 USD (2017-05-29 to 2018-05-27) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528620000004/lndc-20200531.htm#1602317 Filing: 000100528620000004 Input fundies:CapitalExpenditure: 33590000 USD (2017-05-29 to 2018-05-27) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528620000004/lndc-20200531.htm#3260659 Filing: 000100528620000004 The citation records this snapshot. The page link may show a newer release later.
2019 2018-05-28 – 2019-05-26	USD 411,000 Exact value Exact value: 411000 USD 2018-05-28 – 2019-05-26: 411000 USD Inspect Net Income Open source Share or cite Citation for Net Income · LIFECORE BIOMEDICAL, INC. · 2019-05-26 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Net Income: 411000 USD Concept: fundies:NetIncome Period: 2018-05-28 to 2019-05-26 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3ANetIncome&period=2019-05-26&surface=latest&period_type=duration&start=2018-05-28&unit=USD&dimensions= Input fundies:NetIncome: 411000 USD (2018-05-28 to 2019-05-26) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528621000043/lndc-20210530.htm#1481944 Filing: 000100528621000043 The citation records this snapshot. The page link may show a newer release later.	USD 16.02 million Exact value Exact value: 16020000 USD 2018-05-28 – 2019-05-26: 16020000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LIFECORE BIOMEDICAL, INC. · 2019-05-26 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Operating Cash Flow: 16020000 USD Concept: fundies:OperatingCashFlow Period: 2018-05-28 to 2019-05-26 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3AOperatingCashFlow&period=2019-05-26&surface=latest&period_type=duration&start=2018-05-28&unit=USD&dimensions= Input fundies:OperatingCashFlow: 16020000 USD (2018-05-28 to 2019-05-26) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528621000043/lndc-20210530.htm#1214751 Filing: 000100528621000043 The citation records this snapshot. The page link may show a newer release later.	USD 44.73 million Exact value Exact value: 44734000 USD 2018-05-28 – 2019-05-26: 44734000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LIFECORE BIOMEDICAL, INC. · 2019-05-26 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Capital Expenditure: 44734000 USD Concept: fundies:CapitalExpenditure Period: 2018-05-28 to 2019-05-26 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3ACapitalExpenditure&period=2019-05-26&surface=latest&period_type=duration&start=2018-05-28&unit=USD&dimensions= Input fundies:CapitalExpenditure: 44734000 USD (2018-05-28 to 2019-05-26) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528621000043/lndc-20210530.htm#2484659 Filing: 000100528621000043 The citation records this snapshot. The page link may show a newer release later.	−USD 28.71 million Calculation and evidence 16020000 − 44734000 USD Exact free cash flow: -28714000 USD 2018-05-28 – 2019-05-26: 16020000 USD · Inspect Operating Cash Flow · Source 2018-05-28 – 2019-05-26: 44734000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LIFECORE BIOMEDICAL, INC. · 2019-05-26 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Free cash flow: -28714000 USD Concept: free-cash-flow Period: 2018-05-28 to 2019-05-26 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 16020000 USD (2018-05-28 to 2019-05-26) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528621000043/lndc-20210530.htm#1214751 Filing: 000100528621000043 Input fundies:CapitalExpenditure: 44734000 USD (2018-05-28 to 2019-05-26) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528621000043/lndc-20210530.htm#2484659 Filing: 000100528621000043 The citation records this snapshot. The page link may show a newer release later.
2020 2019-05-27 – 2020-05-31	−USD 38.19 million Exact value Exact value: -38191000 USD 2019-05-27 – 2020-05-31: -38191000 USD Inspect Net Income Open source Share or cite Citation for Net Income · LIFECORE BIOMEDICAL, INC. · 2020-05-31 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Net Income: -38191000 USD Concept: fundies:NetIncome Period: 2019-05-27 to 2020-05-31 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3ANetIncome&period=2020-05-31&surface=latest&period_type=duration&start=2019-05-27&unit=USD&dimensions= Input fundies:NetIncome: -38191000 USD (2019-05-27 to 2020-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528623000055/lndc-20220529.htm#1471822 Filing: 000100528623000055 The citation records this snapshot. The page link may show a newer release later.	−USD 17.04 million Exact value Exact value: -17041000 USD 2019-05-27 – 2020-05-31: -17041000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LIFECORE BIOMEDICAL, INC. · 2020-05-31 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Operating Cash Flow: -17041000 USD Concept: fundies:OperatingCashFlow Period: 2019-05-27 to 2020-05-31 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3AOperatingCashFlow&period=2020-05-31&surface=latest&period_type=duration&start=2019-05-27&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17041000 USD (2019-05-27 to 2020-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528623000055/lndc-20220529.htm#1248096 Filing: 000100528623000055 The citation records this snapshot. The page link may show a newer release later.	USD 12.21 million Exact value Exact value: 12214000 USD 2019-05-27 – 2020-05-31: 12214000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LIFECORE BIOMEDICAL, INC. · 2020-05-31 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Capital Expenditure: 12214000 USD Concept: fundies:CapitalExpenditure Period: 2019-05-27 to 2020-05-31 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3ACapitalExpenditure&period=2020-05-31&surface=latest&period_type=duration&start=2019-05-27&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12214000 USD (2019-05-27 to 2020-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528623000055/lndc-20220529.htm#2603682 Filing: 000100528623000055 The citation records this snapshot. The page link may show a newer release later.	−USD 29.26 million Calculation and evidence -17041000 − 12214000 USD Exact free cash flow: -29255000 USD 2019-05-27 – 2020-05-31: -17041000 USD · Inspect Operating Cash Flow · Source 2019-05-27 – 2020-05-31: 12214000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LIFECORE BIOMEDICAL, INC. · 2020-05-31 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Free cash flow: -29255000 USD Concept: free-cash-flow Period: 2019-05-27 to 2020-05-31 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17041000 USD (2019-05-27 to 2020-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528623000055/lndc-20220529.htm#1248096 Filing: 000100528623000055 Input fundies:CapitalExpenditure: 12214000 USD (2019-05-27 to 2020-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528623000055/lndc-20220529.htm#2603682 Filing: 000100528623000055 The citation records this snapshot. The page link may show a newer release later.
2021 2020-06-01 – 2021-05-30	−USD 32.29 million Exact value Exact value: -32294000 USD 2020-06-01 – 2021-05-30: -32294000 USD Inspect Net Income Open source Share or cite Citation for Net Income · LIFECORE BIOMEDICAL, INC. · 2021-05-30 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Net Income: -32294000 USD Concept: fundies:NetIncome Period: 2020-06-01 to 2021-05-30 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3ANetIncome&period=2021-05-30&surface=latest&period_type=duration&start=2020-06-01&unit=USD&dimensions= Input fundies:NetIncome: -32294000 USD (2020-06-01 to 2021-05-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000030/lndc-20230528.htm#4676133 Filing: 000100528624000030 The citation records this snapshot. The page link may show a newer release later.	USD 16.47 million Exact value Exact value: 16471000 USD 2020-06-01 – 2021-05-30: 16471000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LIFECORE BIOMEDICAL, INC. · 2021-05-30 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Operating Cash Flow: 16471000 USD Concept: fundies:OperatingCashFlow Period: 2020-06-01 to 2021-05-30 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3AOperatingCashFlow&period=2021-05-30&surface=latest&period_type=duration&start=2020-06-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 16471000 USD (2020-06-01 to 2021-05-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000030/lndc-20230528.htm#4597737 Filing: 000100528624000030 The citation records this snapshot. The page link may show a newer release later.	USD 19.26 million Exact value Exact value: 19264000 USD 2020-06-01 – 2021-05-30: 19264000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LIFECORE BIOMEDICAL, INC. · 2021-05-30 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Capital Expenditure: 19264000 USD Concept: fundies:CapitalExpenditure Period: 2020-06-01 to 2021-05-30 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3ACapitalExpenditure&period=2021-05-30&surface=latest&period_type=duration&start=2020-06-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 19264000 USD (2020-06-01 to 2021-05-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528623000055/lndc-20220529.htm#2569001 Filing: 000100528623000055 The citation records this snapshot. The page link may show a newer release later.	−USD 2.79 million Calculation and evidence 16471000 − 19264000 USD Exact free cash flow: -2793000 USD 2020-06-01 – 2021-05-30: 16471000 USD · Inspect Operating Cash Flow · Source 2020-06-01 – 2021-05-30: 19264000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LIFECORE BIOMEDICAL, INC. · 2021-05-30 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Free cash flow: -2793000 USD Concept: free-cash-flow Period: 2020-06-01 to 2021-05-30 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 16471000 USD (2020-06-01 to 2021-05-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000030/lndc-20230528.htm#4597737 Filing: 000100528624000030 Input fundies:CapitalExpenditure: 19264000 USD (2020-06-01 to 2021-05-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528623000055/lndc-20220529.htm#2569001 Filing: 000100528623000055 The citation records this snapshot. The page link may show a newer release later.
2022 2021-05-31 – 2022-05-29	−USD 116.72 million Exact value Exact value: -116715000 USD 2021-05-31 – 2022-05-29: -116715000 USD Inspect Net Income Open source Share or cite Citation for Net Income · LIFECORE BIOMEDICAL, INC. · 2022-05-29 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Net Income: -116715000 USD Concept: fundies:NetIncome Period: 2021-05-31 to 2022-05-29 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3ANetIncome&period=2022-05-29&surface=latest&period_type=duration&start=2021-05-31&unit=USD&dimensions= Input fundies:NetIncome: -116715000 USD (2021-05-31 to 2022-05-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000124/lndc-20240526.htm#1359976 Filing: 000100528624000124 The citation records this snapshot. The page link may show a newer release later.	−USD 22.59 million Exact value Exact value: -22593000 USD 2021-05-31 – 2022-05-29: -22593000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LIFECORE BIOMEDICAL, INC. · 2022-05-29 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Operating Cash Flow: -22593000 USD Concept: fundies:OperatingCashFlow Period: 2021-05-31 to 2022-05-29 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3AOperatingCashFlow&period=2022-05-29&surface=latest&period_type=duration&start=2021-05-31&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22593000 USD (2021-05-31 to 2022-05-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000124/lndc-20240526.htm#1088788 Filing: 000100528624000124 The citation records this snapshot. The page link may show a newer release later.	USD 26.23 million Exact value Exact value: 26226000 USD 2021-05-31 – 2022-05-29: 26226000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LIFECORE BIOMEDICAL, INC. · 2022-05-29 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Capital Expenditure: 26226000 USD Concept: fundies:CapitalExpenditure Period: 2021-05-31 to 2022-05-29 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3ACapitalExpenditure&period=2022-05-29&surface=latest&period_type=duration&start=2021-05-31&unit=USD&dimensions= Input fundies:CapitalExpenditure: 26226000 USD (2021-05-31 to 2022-05-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528623000055/lndc-20220529.htm#2534188 Filing: 000100528623000055 The citation records this snapshot. The page link may show a newer release later.	−USD 48.82 million Calculation and evidence -22593000 − 26226000 USD Exact free cash flow: -48819000 USD 2021-05-31 – 2022-05-29: -22593000 USD · Inspect Operating Cash Flow · Source 2021-05-31 – 2022-05-29: 26226000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LIFECORE BIOMEDICAL, INC. · 2022-05-29 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Free cash flow: -48819000 USD Concept: free-cash-flow Period: 2021-05-31 to 2022-05-29 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22593000 USD (2021-05-31 to 2022-05-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000124/lndc-20240526.htm#1088788 Filing: 000100528624000124 Input fundies:CapitalExpenditure: 26226000 USD (2021-05-31 to 2022-05-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528623000055/lndc-20220529.htm#2534188 Filing: 000100528623000055 The citation records this snapshot. The page link may show a newer release later.
2023 2022-05-30 – 2023-05-28	−USD 99.56 million Exact value Exact value: -99563000 USD 2022-05-30 – 2023-05-28: -99563000 USD Inspect Net Income Open source Share or cite Citation for Net Income · LIFECORE BIOMEDICAL, INC. · 2023-05-28 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Net Income: -99563000 USD Concept: fundies:NetIncome Period: 2022-05-30 to 2023-05-28 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3ANetIncome&period=2023-05-28&surface=latest&period_type=duration&start=2022-05-30&unit=USD&dimensions= Input fundies:NetIncome: -99563000 USD (2022-05-30 to 2023-05-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000124/lndc-20240526.htm#1359114 Filing: 000100528624000124 The citation records this snapshot. The page link may show a newer release later.	−USD 17.44 million Exact value Exact value: -17441000 USD 2022-05-30 – 2023-05-28: -17441000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LIFECORE BIOMEDICAL, INC. · 2023-05-28 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Operating Cash Flow: -17441000 USD Concept: fundies:OperatingCashFlow Period: 2022-05-30 to 2023-05-28 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3AOperatingCashFlow&period=2023-05-28&surface=latest&period_type=duration&start=2022-05-30&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17441000 USD (2022-05-30 to 2023-05-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000124/lndc-20240526.htm#1088130 Filing: 000100528624000124 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2024 2023-05-29 – 2024-05-26	USD 12.01 million Exact value Exact value: 12013000 USD 2023-05-29 – 2024-05-26: 12013000 USD Inspect Net Income Open source Share or cite Citation for Net Income · LIFECORE BIOMEDICAL, INC. · 2024-05-26 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Net Income: 12013000 USD Concept: fundies:NetIncome Period: 2023-05-29 to 2024-05-26 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3ANetIncome&period=2024-05-26&surface=latest&period_type=duration&start=2023-05-29&unit=USD&dimensions= Input fundies:NetIncome: 12013000 USD (2023-05-29 to 2024-05-26) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000108/lfcr-20250525.htm#861957 Filing: 000100528625000108 The citation records this snapshot. The page link may show a newer release later.	USD 257,000 Exact value Exact value: 257000 USD 2023-05-29 – 2024-05-26: 257000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LIFECORE BIOMEDICAL, INC. · 2024-05-26 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Operating Cash Flow: 257000 USD Concept: fundies:OperatingCashFlow Period: 2023-05-29 to 2024-05-26 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3AOperatingCashFlow&period=2024-05-26&surface=latest&period_type=duration&start=2023-05-29&unit=USD&dimensions= Input fundies:OperatingCashFlow: 257000 USD (2023-05-29 to 2024-05-26) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000108/lfcr-20250525.htm#882619 Filing: 000100528625000108 The citation records this snapshot. The page link may show a newer release later.	USD 18.4 million Exact value Exact value: 18395000 USD 2023-05-29 – 2024-05-26: 18395000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LIFECORE BIOMEDICAL, INC. · 2024-05-26 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Capital Expenditure: 18395000 USD Concept: fundies:CapitalExpenditure Period: 2023-05-29 to 2024-05-26 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3ACapitalExpenditure&period=2024-05-26&surface=latest&period_type=duration&start=2023-05-29&unit=USD&dimensions= Input fundies:CapitalExpenditure: 18395000 USD (2023-05-29 to 2024-05-26) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000108/lfcr-20250525.htm#884587 Filing: 000100528625000108 The citation records this snapshot. The page link may show a newer release later.	−USD 18.14 million Calculation and evidence 257000 − 18395000 USD Exact free cash flow: -18138000 USD 2023-05-29 – 2024-05-26: 257000 USD · Inspect Operating Cash Flow · Source 2023-05-29 – 2024-05-26: 18395000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LIFECORE BIOMEDICAL, INC. · 2024-05-26 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Free cash flow: -18138000 USD Concept: free-cash-flow Period: 2023-05-29 to 2024-05-26 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 257000 USD (2023-05-29 to 2024-05-26) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000108/lfcr-20250525.htm#882619 Filing: 000100528625000108 Input fundies:CapitalExpenditure: 18395000 USD (2023-05-29 to 2024-05-26) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000108/lfcr-20250525.htm#884587 Filing: 000100528625000108 The citation records this snapshot. The page link may show a newer release later.
2025 2024-05-27 – 2025-05-25	−USD 38.72 million Exact value Exact value: -38717000 USD 2024-05-27 – 2025-05-25: -38717000 USD Inspect Net Income Open source Share or cite Citation for Net Income · LIFECORE BIOMEDICAL, INC. · 2025-05-25 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Net Income: -38717000 USD Concept: fundies:NetIncome Period: 2024-05-27 to 2025-05-25 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3ANetIncome&period=2025-05-25&surface=latest&period_type=duration&start=2024-05-27&unit=USD&dimensions= Input fundies:NetIncome: -38717000 USD (2024-05-27 to 2025-05-25) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000108/lfcr-20250525.htm#861185 Filing: 000100528625000108 The citation records this snapshot. The page link may show a newer release later.	−USD 206,000 Exact value Exact value: -206000 USD 2024-05-27 – 2025-05-25: -206000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · LIFECORE BIOMEDICAL, INC. · 2025-05-25 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Operating Cash Flow: -206000 USD Concept: fundies:OperatingCashFlow Period: 2024-05-27 to 2025-05-25 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3AOperatingCashFlow&period=2025-05-25&surface=latest&period_type=duration&start=2024-05-27&unit=USD&dimensions= Input fundies:OperatingCashFlow: -206000 USD (2024-05-27 to 2025-05-25) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000108/lfcr-20250525.htm#882000 Filing: 000100528625000108 The citation records this snapshot. The page link may show a newer release later.	USD 13.42 million Exact value Exact value: 13415000 USD 2024-05-27 – 2025-05-25: 13415000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · LIFECORE BIOMEDICAL, INC. · 2025-05-25 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Capital Expenditure: 13415000 USD Concept: fundies:CapitalExpenditure Period: 2024-05-27 to 2025-05-25 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286/explain?concept=fundies%3ACapitalExpenditure&period=2025-05-25&surface=latest&period_type=duration&start=2024-05-27&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13415000 USD (2024-05-27 to 2025-05-25) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000108/lfcr-20250525.htm#883996 Filing: 000100528625000108 The citation records this snapshot. The page link may show a newer release later.	−USD 13.62 million Calculation and evidence -206000 − 13415000 USD Exact free cash flow: -13621000 USD 2024-05-27 – 2025-05-25: -206000 USD · Inspect Operating Cash Flow · Source 2024-05-27 – 2025-05-25: 13415000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · LIFECORE BIOMEDICAL, INC. · 2025-05-25 LIFECORE BIOMEDICAL, INC. (edgar:1005286) Free cash flow: -13621000 USD Concept: free-cash-flow Period: 2024-05-27 to 2025-05-25 Values: Latest reported Published: 2026-11-02T19:46:04Z Snapshot: f54978c426341640b206db9a138db1d405d8749ab9c75df3002be8d777f31dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005286?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -206000 USD (2024-05-27 to 2025-05-25) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000108/lfcr-20250525.htm#882000 Filing: 000100528625000108 Input fundies:CapitalExpenditure: 13415000 USD (2024-05-27 to 2025-05-25) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000108/lfcr-20250525.htm#883996 Filing: 000100528625000108 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

204 filings · 6,755 latest values · 6,755 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001005286, 1005286, LFCR, LNDC, edgar:1005286, lndc

Also known as LANDEC CORP \CA\, LANDEC CORPORATION, LIFECORE BIOMEDICAL, INC., LIFECORE BIOMEDICAL, INC. \DE\

LIFECORE BIOMEDICAL, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2019 2018-05-28 – 2019-05-26

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation